美股市场个股详情
WST West Pharmaceutical Services
- 364.070
- -0.950-0.26%
交易中 05/06 11:04 (美东)
265.20亿总市值48.03市盈率TTM
369.170最高价364.070最低价4.66万股成交量365.850今开365.020昨收1708.30万成交额0.06%换手率46.20市盈率(静)7284.32万总股本415.02752周最高9.89市净率263.41亿流通值309.89552周最低0.78股息TTM7235.17万流通股472.351历史最高0.21%股息率TTM1.40%振幅3.190历史最低366.831平均价1股每手
West Pharmaceutical Services股票讨论区
登录发表评论
RECAP
U.S. equity indexes rose after Thursday, with the $纳斯达克综合指数(.IXIC.US$ lagging the pack, as investors weighed retail sales and jobless claims ahead of more inflation data this week.
The $标普500指数(.SPX.US$ rose 0.58% to 5,029, a new closing high with the $道琼斯指数(.DJI.US$ up 0.91% to 38,664. The $纳斯达克综合指数(.IXIC.US$ was moderately higher at 15,906, af...
U.S. equity indexes rose after Thursday, with the $纳斯达克综合指数(.IXIC.US$ lagging the pack, as investors weighed retail sales and jobless claims ahead of more inflation data this week.
The $标普500指数(.SPX.US$ rose 0.58% to 5,029, a new closing high with the $道琼斯指数(.DJI.US$ up 0.91% to 38,664. The $纳斯达克综合指数(.IXIC.US$ was moderately higher at 15,906, af...
41
5
Analysts worry about the company's shifting tone and the enduring effect of clients' inventory management on West's finances. Doubts also arise about the company's demand visibility and if current trends suggest a fundamental issue in West's base business.
Jefferies analyst David Windley sees FDA approvals of GLP-1s for obesity treatment as a huge opportunity for the manufacturing supply chain. He also notes high rivalry in the injectable fill/finish market. Windley upgraded West Pharmaceutical to Buy, raising its price target by 66% to $536, citing its global footprint and capacity to meet growing GLP-1s demand.
The market sentiment around West Pharmaceutical Services hasn't changed much over the past five years, with the share price seemingly reacting to the EPS. The recent improvement in TSR could indicate that the business is getting better with time.
1
The 4- and 5-star rated Dividend Aristocrats for 2024 include Abbott Laboratories, AbbVie Inc., Air Products & Chemicals, and others such as Coca-Cola Co., McDonald's Corp., Walmart Inc., and West Pharmaceuticals.
1
1. $苹果(AAPL.US$ : +59,918% (20 year total return)
2. $怪物饮料(MNST.US$ : +59,299%
3. $英伟达(NVDA.US$ : +28,712%
4. $Intuitive Machines(LUNR.US$: +18,221%
5. $Booking Holdings(BKNG.US$ : +16,299%
6. $奈飞(NFLX.US$ : +13,442%
7. $Old Dominion Freight Line(ODFL.US$ : +9,403%
8. $SBA通信公司(SBAC.US$ : +7,356%
9. $科帕特(CPRT.US$ : +6,592%
10. $再生元制药公司(REGN.US$ : +6,296%
11. $亚马逊(AMZN.US$ ...
2. $怪物饮料(MNST.US$ : +59,299%
3. $英伟达(NVDA.US$ : +28,712%
4. $Intuitive Machines(LUNR.US$: +18,221%
5. $Booking Holdings(BKNG.US$ : +16,299%
6. $奈飞(NFLX.US$ : +13,442%
7. $Old Dominion Freight Line(ODFL.US$ : +9,403%
8. $SBA通信公司(SBAC.US$ : +7,356%
9. $科帕特(CPRT.US$ : +6,592%
10. $再生元制药公司(REGN.US$ : +6,296%
11. $亚马逊(AMZN.US$ ...
7
2
There's a gap between West Pharmaceutical Services' high P/E ratio and its forecasted market-matching growth. Investors appear more bullish than analysts, but this earnings growth level could impact share price, making the high share price difficult to justify.
West Pharmaceutical Services, with its surplus and larger cash amount than debt, has a conservative balance sheet, indicating an ability to easily eliminate debt. With a free cash flow being 53% of EBIT, the company is in a strong position to pay down debt when needed.
West Pharmaceutical Services' stock shows promising performance and price momentum. Stable market sentiment and improvements in one-year TSR indicate recent performance enhancement.
W...
9
暂无评论
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅
Qulynnitha Bowman : How much money do i need to invest in stocks
102556055 : $富途控股 (FUTU.US)$
Cypher : “$Microsoft(MSFT.US)$'s OpenAi released a short 60-minute video.”
The video is 60 seconds, not minutes. The writing quality on this platform has really been down lately. I’ve caught way too many errors.
bellalita : good news
Malik ritduan : oo